UniD Manufacturing

What we do: UniD Manufacturing is a pioneering Contract Development and Manufacturing Organization (CDMO) specializing exclusively in micro and macro implants based on polymeric formulations for sustained drug release. The company designs and manufactures implants using bioresorbable, biodegradable, and non-biodegradable polymers, enabling drug release durations ranging from a single day up to nine years. UniD supports pharmaceutical and biotech partners with end-to-end services from research and development through clinical phases to commercialization, leveraging over 20 years of expertise in polymer long-acting formulations. Their integrated platform includes tailor-made GMP-approved equipment and clean rooms, enabling production of high-potent APIs and a wide range of dosage forms such as vaginal rings, ophthalmic implants, and inserts.

Location: Headquartered in Seraing, Belgium, UniD Manufacturing operates modern facilities in the Liège Science Park, including a new 6,250 m² production plant designed to meet and exceed European energy efficiency and GMP standards.

History: UniD Manufacturing originated as a spin-off from EyeD Pharma to capitalize on a highly specialized in-house developed production process for micro-implants. Since its founding, the company has evolved into a global leader in the pharmaceutical CDMO sector dedicated to polymer-based sustained release implants. 2024 marks a significant milestone as UniD fully opens its CDMO services to external customers, expanding beyond ocular implants to other therapeutic areas.

Organization & Culture: With a dynamic team of approximately 50-99 employees, UniD fosters a culture grounded in integrity, innovation, and excellence. Collaboration and mutual respect are core values, creating an environment where every voice is valued and innovative ideas are encouraged. The company emphasizes agility, flexibility, and a tailored approach to meet client needs efficiently.

Recent Developments: UniD is investing strategically in artificial intelligence to enhance data analysis and process robustness. The company also recently moved to a new GMP-approved facility with extensive clean room capacity and is expanding its manufacturing capabilities with a new large-scale plant in Liège, Belgium, to meet growing demand.